« Previous Next » Contraception
Volume 67, Issue 4 , Pages 281-285 , April 2003

The acceptability of combined oral hormonal contraceptives in Shanghai, People’s Republic of China

Junling Chen
- Shanghai Institute of Family Planning Technical Instruction, 145 Guangyuan Road, Shanghai 200030, People’s Republic of China
- Corresponding author. Tel.: +1-86-21-64334629; fax: +86-21-64748015.
Karen B Smith
- Contraceptive Development Network, Centre for Reproductive Biology, University of Edinburgh, The Chancellor’s Building, 49 Little France, Crescent, Edinburgh EH16 4SB UK
Susan Morrow
- Contraceptive Development Network, Centre for Reproductive Biology, University of Edinburgh, The Chancellor’s Building, 49 Little France, Crescent, Edinburgh EH16 4SB UK
Anna Glasier
- Contraceptive Development Network, Centre for Reproductive Biology, University of Edinburgh, The Chancellor’s Building, 49 Little France, Crescent, Edinburgh EH16 4SB UK
Linan Cheng
- Shanghai Institute of Family Planning Technical Instruction, 145 Guangyuan Road, Shanghai 200030, People’s Republic of China

Received 2 May 2002 ,Revised 18 September 2002 ,Accepted 7 November 2002.

References

Xiao BL, Zhao BG. Current practice of family planning in China. Int J Gynaecol Obstet. 1997;58:59–67
Yao Z, Yang X, Xiao Z, et al. A cross-section survey of induced abortions in Shanghai. Chin J Fam Plann. 1993;3:86–91
Liu Y, Tian K, Huang Z, San M, Chi X. Study on determinants and preventive strategy of induced abortion among married women of child-bearing age in rural Shandong province. J Reprod Med. 1996;5:79–86
Peipert JF, Gutmann J. Oral contraceptive risk assessment (a survey of 247 educated women). Obstet Gynecol. 1993;82:112–117
- MEDLINE
Tessler SL, Peipert JF. Perceptions of contraceptive effectiveness and health effects of oral contraception. Wom Health Iss. 1997;7:400–406
Fuchs N, Prinz H, Kioch U. Attitudes to current oral contraceptive use and future developments (the women’s perspective). Eur J Contracept Reprod Health Care. 1996;1:275–284
- MEDLINE
- CrossRef
Bryden PJ, Fletcher P. Knowledge of the risks and benefits associated with oral contraception in a university-aged sample of users and non-users. Contraception. 2001;63:223–227
Edwards JE, Oldman A, Smith L, MeQuay HJ, Moore RA. Women’s knowledge of, and attitudes to, contraceptive effectiveness, and adverse health effects. Br J Fam Plann. 2000;26:73–80
- MEDLINE
Guo Y, Fang K, Shi Y. A dynamic study of contraceptive choice and factors influencing the choice among newly married couples. Reprod Contracept. 1994;14:56–64
Abma JC, Chandra A, Mosher WD, Peterson LS, Piccinino LJ. Fertility, family planning, and women’s health (new data from the 1995 National Survey of Family Growth). Vital Health Stat. 1997;23:1–114
McEwan J, Wadsworth J, Johnson AM, Wellings K. Changes in the use of contraceptive methods in England and Wales over two decades (Margaret Bone’s surveys and the National Survey of Sexual Attitudes and Lifestyles). Br J Fam Plann. 1997;23:5–8
Piccinino LJ, Mosher WD. Trends in contraceptive use in the United States (1982–1995). Fam Plann Perspect. 1998;30:4–10
46
- MEDLINE
- CrossRef
Archer DF, Maheux R, DelConte A, O’Brien FB. A new low-dose monophasic combination oral contraceptive (Alesse™) with levonorgestrel 100 μg and ethinyl estradiol 20 μg. Contraception. 1997;55:139–144
Oosterbaan HP. An open-label study of the effects of a 24-day regimen of gestodene 60 μg/ethinylestradiol 15 μg on endometrial histological findings in healthy women. Eur J Contracept Reprod Health Care. 1999;4(Suppl 2):S3–S8
Gestodene Study Group 322 . The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 μg and ethinylestradiol 15 μg. Eur J Contracept Reprod Health Care. 1999;4(Suppl 2):S9–S15
Rosenberg MJ, Waugh MS. Improving oral contraceptive use: factors associated with poor compliance. Proceedings of American College of Obstetricians and Gynecologists Annual Meeting, Denver, Colorado, 1996